Heart transplant recipients can improve fitness and perform high intensity workoutsJuly 06, 2009Heart transplant recipients' cardio-respiratory fitness is around 30 to 50 per cent lower than age-matched healthy sedentary individuals. As a result, exercise rehabilitation should be very important to these patients, and a University of Alberta study shows they can improve their overall physical fitness. Mark Haykowsky, in the Faculty of Rehabilitation Medicine, led the largest randomized exercise intervention trial in heart-transplant patients, which was published in the April edition of American Journal of Transplantation. The study involved 43 participants, half sedentary, and the other half on a 12-week exercise program. He found that exercise improved cardio-respiratory fitness, muscle mass and maximal strength; surprisingly, however, exercise training didn't improve heart or blood-vessel function. Those exercising improved the size of the muscle mass, but blood vessels were still hardened and the heart's ability to fill and relax was not improved. The study's findings show that people who are classified as "long-term post-transplant" are trainable. The results also served as a springboard for Dwight Kroening, who went on to become the first heart-transplant recipient to complete an Ironman triathlon (2.4 mile swim, 112 mile bike and 26 mile run). And the inspiration goes both ways, as Haykowsky went on to train and complete his first marathon because of Kroening's own determination. University of Alberta |
|||||||||||||||||||||
| Related Heart Transplant Current Events and Heart Transplant News Articles Young athletes need dual screening tests for heart defects, study suggests To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins. Texas Children's discharges first pediatric patient with implanted mechanical heart device Texas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions. UT Southwestern patient first in North Texas to receive newest-generation heart failure device UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant. First heart patients implanted with next-generation mechanical heart pump Three patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first in the United States to be implanted with a next-generation artificial heart pump called the DuraHeart™ Left-Ventricular Assist System. Exercise is safe, improves quality of life in patients with chronic heart failure Regular exercise is safe for heart failure patients and may slightly lower their risk of death or hospitalization, according to results from the largest and most comprehensive clinical trial to examine the effects of exercise in chronic heart failure patients. Artificial pump effectively backs up failing hearts Patients with severe heart failure can be bridged to eventual transplant by a new, smaller and lighter implantable heart pump, according to a just-completed study of the device. Older patients with 1 type of heart failure may receive little or no benefit from drugs People over 80 years of age suffering from a certain type of heart failure do not appear to benefit from most commonly prescribed heart medications, according to a study conducted at the Cedars-Sinai Heart Institute and published in the March 15 issue of The American Journal of Cardiology. Hebrew University scientist develop technique for eliminating reblockage of arteries An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem. First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure. First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure. More Heart Transplant Current Events and Heart Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||